PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för hydrazinocurcumin. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

9 hits

Bibliografisk träff 2014-01-01

Preventive effect of hydrazinocurcumin on carcinogenesis of diethylnitrosamine-induced hepatocarcinoma in male SD rats.

Zhao JA, Peng L, Geng CZ, Liu YP, Wang X, Yang HC, Wang SJ.

Asian Pac J Cancer Prev · research support, non-u.s. gov't; journal article · DOI 10.7314/apjcp.2014.15.5.2115

Bibliografisk träff 2013-06-25

Hydrazinocurcumin Encapsuled nanoparticles "re-educate" tumor-associated macrophages and exhibit anti-tumor effects on breast cancer following STAT3 suppression.

Zhang X, Tian W, Cai X, Wang X, Dang W, Tang H, Cao H, Wang L, Chen T.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0065896

Bibliografisk träff 2012-08-30

Curcumin is an inhibitor of calcium/calmodulin dependent protein kinase II.

Mayadevi M, Sherin DR, Keerthi VS, Rajasekharan KN, Omkumar RV.

Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2012.08.029

Bibliografisk träff 2011-12-14

The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition.

Wang X, Zhang Y, Zhang X, Tian W, Feng W, Chen T.

Int J Oncol · research support, non-u.s. gov't; research-article; journal article · DOI 10.3892/ijo.2011.1298

Bibliografisk träff 2010-08-01

Nitric oxide-mediated histone hyperacetylation in oral cancer: target for a water-soluble HAT inhibitor, CTK7A.

Arif M, Vedamurthy BM, Choudhari R, Ostwal YB, Mantelingu K, Kodaganur GS, Kundu TK.

Chem Biol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.chembiol.2010.06.014

Bibliografisk träff 2008-02-01

Genome-wide drug-induced haploinsufficient screening of fission yeast for identification of hydrazinocurcumin targets.

Baek ST, Kim DU, Han S, Woo IS, Nam M, Kim L, Heo KS, Lee H, Hwang HR, Choi SJ, Won M, Lee M, Park SK, Lee S, Kwon HJ, Maeng PJ, Park HM, Park Y, Kim D, Hoe KL.

J Microbiol Biotechnol · research support, non-u.s. gov't; journal article

Bibliografisk träff 2007-09-26

Simultaneous determination of hydrazinocurcumin and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation.

Rathore R, Jain JP, Srivastava A, Jachak SM, Kumar N.

J Pharm Biomed Anal · validation study; journal article · DOI 10.1016/j.jpba.2007.09.019

Bibliografisk träff 2002-09-01

Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation.

Shim JS, Kim DH, Jung HJ, Kim JH, Lim D, Lee SK, Kim KW, Ahn JW, Yoo JS, Rho JR, Shin J, Kwon HJ.

Bioorg Med Chem · research support, non-u.s. gov't; duplicate publication; journal article · DOI 10.1016/s0968-0896(02)00129-3

Bibliografisk träff 2002-08-01

Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation.

Shim JS, Kim DH, Jung HJ, Kim JH, Lim D, Lee SK, Kim KW, Ahn JW, Yoo JS, Rho JR, Shin J, Kwon HJ.

Bioorg Med Chem · research support, non-u.s. gov't; duplicate publication; journal article · DOI 10.1016/s0968-0896(02)00116-5